(Q78074858)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Correlations of soluble interleukin-2 and tumor necrosis factor type II receptors with immunologic and virologic responses under HAART (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

5

G Chêne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

F Bonnet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

M Savès

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

P H Morlat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

C Droz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

E Peuchant

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

N Bernard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

D Lacoste

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

R Salamon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

J Beylot

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

75-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11998896%20AND%20SRC:MED&resulttype=core&format=json

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

10 December 2019

cites work

1 reference

12 December 2020

Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

1 reference

12 December 2020

Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

1 reference

12 December 2020

The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

1 reference

12 December 2020

The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults

1 reference

12 December 2020

Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?

1 reference

12 December 2020

Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.

1 reference

12 December 2020

HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state

1 reference

12 December 2020

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team

1 reference

12 December 2020

Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.

1 reference

12 December 2020

Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements

1 reference

12 December 2020

Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection.

1 reference

12 December 2020

Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro

1 reference

12 December 2020

Effect of HAART on natural history of AIDS-related opportunistic disorders

1 reference

12 December 2020

Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: a comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and beta2-microglobu

1 reference

12 December 2020

The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro

1 reference

12 December 2020

Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat

1 reference

12 December 2020

CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study

1 reference

12 December 2020

Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea

1 reference

12 December 2020

Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy

1 reference

12 December 2020

Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

12 December 2020

Protease inhibitor and triple-drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of treatment

1 reference

12 December 2020

Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure

1 reference

12 December 2020